- CUF will invest €55 million in a new chlorine production unit in Torrelavega.
- The asset transfer is expected in Q1 2018 after the shutdown of the mercury-based unit on December 11, 2017.
- Solvay's employees will not be transferred and a social plan will be implemented.
- CUF's new unit will use membrane cell-based technology.
Agreement Details
Solvay and CUF have agreed to sell Solvay’s electrochemistry production assets in Torrelavega, Spain, to CUF. This transaction involves Solvay Química S.L. and Altamira – Electroquímica del Cantábrico, S.A., a new affiliate of CUF.
Investment and Technology
CUF plans to invest approximately €55 million to build a new chlorine and derivatives production unit in Torrelavega. The new unit will utilize membrane cell-based technology, which is considered the best available technology for manufacturing these products.
Employee and Social Plan
Solvay’s employees will not be transferred to CUF. Solvay will involve the local Works Council representatives in implementing a social plan to address this transition.
Timeline and Shutdown
Solvay expects to transfer the assets in the first quarter of 2018. The current chlorine production unit, which uses mercury-based technology, will be shut down on December 11, 2017.
Strategic Impact
This agreement will enable CUF to expand its production and business operations in Spain, strengthening its position in the Iberian chlorine and chlorinated products market. For Solvay, the deal consolidates employment levels within its Torrelavega industrial complex and reinforces the site's role as a significant industrial park in the Cantabria region.
